Research Topics
| Joseph BikowskiSummaryAffiliation: Bikowski Skin Care Center Country: USA Publications
|
Detail Information
Publications
The pharmacologic therapy of rosacea: a paradigm shift in progressJoseph B Bikowski
Cutis 75:27-32; discussion 33-6. 2005..A paradigm shift in progress in the management of rosacea encompasses the use of these and other agents either alone or, increasingly, in different combinations, based on the subtype of rosacea...- Lymphangioma circumscriptum: treatment with hypertonic saline sclerotherapyJoseph B Bikowski
Department of Dermatology, Ohio State University, Columbus, Ohio, USA
J Am Acad Dermatol 53:442-4. 2005.... - Subantimicrobial dose doxycycline for acne and rosaceaJoseph B Bikowski
The Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Skinmed 2:234-45. 2003..The results of subantimicrobial dose doxycycline treatment in early trials support its benefits and further investigation in acne and rosacea... - Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acneJoseph Bikowski
Ohio State University, Columbus, OH, USA
J Drugs Dermatol 7:590-5. 2008..This article presents a series of patients from 2 private dermatologic practices treated with a new BPO microsphere cream formulation both as monotherapy and in combination with other acne drugs... - Case studies assessing a new skin barrier repair cream for the treatment of atopic dermatitisJoseph Bikowski
Bikowski Skin Care Center, Sewickley, PA 15143, USA
J Drugs Dermatol 8:1037-41. 2009..This article describes the pathogenic rationale for using a barrier repair cream for the treatment of AD and discusses case report results focused on its clinical benefit for AD... - Molluscum contagiosum: the need for physician intervention and new treatment optionsJoseph B Bikowski
Bikowski Skin Care Center, Sewickley Station, Sewickley, Pennsylvania 15143, USA
Cutis 73:202-6. 2004..In addition to the commonly administered treatments (ie, physical and chemical destruction), novel treatment opportunities exist, including immunomodulated therapy with imiquimod... - Hyperkeratosis of the heels: treatment with salicylic acid in a novel delivery systemJoseph Bikowski
Bikowski Skin Care Center, 500 Chadwick Street, Sewickley, PA 15143, USA
Skinmed 3:350-1. 2004..After I week of topical treatment with salicylic add 6%, multivesicular cream applied b.i.d. to the left heel only, there was rapid resolution of both hyperkeratosis and pain (Figure 4)... - Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic optionsJoseph Bikowski
Department of Dermatology, Ohio State University, Columbus, USA
Cutis 78:13-20. 2006..Overall, these combinations appeared to be well-tolerated, effective, and, as reported in the case studies, adaptable to common clinical practice... - Topical metronidazole combination therapy in the clinical management of rosaceaJames Q Del Rosso
Department of Dermatology, University of Nevada School of Medicine, Las Vegas, NV, USA
J Drugs Dermatol 4:473-80. 2005..In this paper, the results of observational experience evaluating topical metronidazole 0.75% gel used in combination with other topical rosacea therapies and/or subantimicrobial dose doxycycline are reported... - Multivesicular emulsion: a novel, controlled-release delivery system for topical dermatological agentsJoseph Bikowski
Bikowski Skin Care Center, Sewickley, PA, USA
J Drugs Dermatol 5:942-6. 2006..Subjects' self-assessment was clearly indicative of the excellent cosmetic elegance of the multivesicular emulsion system... - Facial seborrheic dermatitis: a report on current status and therapeutic horizonsJoseph Bikowski
Bikowski Skin Care Center, Sewickely, PA 15143, USA
J Drugs Dermatol 8:125-33. 2009..A recent exploratory study supports the efficacy and safety of azelaic acid 15% gel in seborrheic dermatitis. Azelaic acid may be especially valuable in this application because of its efficacy in treating concomitant rosacea and acne... - A new approach to comparing efficacy results from clinical trials of topical acne vulgaris treatmentsJoseph Bikowski
Bikowski Skin Care Center, Sewickley, PA 15143, USA
J Drugs Dermatol 6:688-92. 2007..Clinicians should be cautioned that this method only allows for broad comparisons and does not establish definitive differences between treatments... - The position not the presence of the halogen in corticosteroids influences potency and side effectsJoseph Bikowski
Bikowski Skin Care Center, Sewickley, PA, USA
J Drugs Dermatol 5:125-30. 2006..A greater understanding of the role of halogenation in determining corticosteroid potency and side effects will clarify why all halogenated steroids are not the same... - Case studiesJoseph B Bikowski
Bikowski Skincare Center, Sewickley, Pennsylvania, USA
Cutis 77:17-21. 2006 - Rosacea: where are we now?Joseph B Bikowski
Bikowski Skin Care Center, 500 Chadwick St, Sewickley, PA 15143, USA
J Drugs Dermatol 3:251-61. 2004.... - Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel (Duac) as monotherapy and in combinationJoseph B Bikowski
Bikowski Skin Care Center, Sewickley, PA 15143, USA
J Drugs Dermatol 4:164-71. 2005..Improvement is noted by means of photographic, physician, and/or patient assessments at baseline and follow-up visits... - Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoidsJoseph B Bikowski
Bikowski Skin Care Center, Sewickley Station, Sewickley, PA 15143-1051, USA
J Drugs Dermatol 4:41-7. 2005..Tazarotene is a prodrug metabolized to tazarotenic acid that modulates cellular differentiation, desquamation, and inflammation... - A closer look at truncal acne vulgaris: prevalence, severity, and clinical significanceJames Q Del Rosso
University of Nevada School of Medicine, Touro University College of Osteopathic Medicine Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, NV, USA
J Drugs Dermatol 6:597-600. 2007..A grading system for truncal acne vulgaris is also presented. The majority of patients presenting with truncal acne vulgaris exhibited mild to moderate severity and more than 75% were interested in treatment for truncal acne lesions...